The Companion Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Companion Diagnostics Market?
The market size of the Companion Diagnostics Global Market Report 2025 has seen substantial growth in the past few years. It is projected to escalate from $7.34 billion in 2024 to $8.75 billion in 2025, recording a compound annual growth rate (CAGR) of 19.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Companion Diagnostics Industry?
The Companion Diagnostics Global Market Report 2025 predicts that by 2029, the market size for companion diagnostics will reach $19.07 billion, expanding at a compound annual growth rate (CAGR) of 21.5%.
Download Your Free Sample of the 2025 Companion Diagnostics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Companion Diagnostics Market?
The key drivers in the companion diagnostics market are:
• Development of targeted therapy
• Rise in diagnostic procedures for infectious and rare diseases
• Growth in biomarker-based drug development
• Expansion of point-of-care testing and liquid biopsy applications
Global Market Segmentation: Identifying Major Companion Diagnostics Industry Segments
The companion diagnostics market covered in this report is segmented –
1) By Product And Service: Assays, Kits And Reagents, Software And Services
2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry
3) By Indication: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma
4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations
Pre-order the 2025 Companion Diagnostics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Companion Diagnostics Market?
The key trends in the heart pump devices market are:
• Future trends in the companion diagnostics market include advancements in immunotherapy and immunology techniques.
• The application of artificial intelligence and machine learning in diagnostics is an upcoming trend.
• The market is expected to be shaped by product innovations and technological improvements.
• Strategic collaborations and partnerships have emerged as a key trend in the industry.
Who Are the Top Competitors & Leading Players in the Companion Diagnostics Market?
Major companies in the companion diagnostics market are:
• F Hoffmann-La Roche Ltd.
• Agilent Technologies Inc.
• Qiagen NV
• Thermo Fisher Scientific Inc.
• Abbott Laboratories Inc.
• Abnova Corp.
• Amoy Diagnostics Co. Ltd.
• ARUP Laboratories
• Bayer AG
• Biomerieux SA
• Danaher Corporation
• Guardant Health Inc.
• Illumina Inc.
• Myriad Genetics Inc.
• Siemens Healthcare GmbH
• Almac Group
• Caris Life Sciences
• Cepheid Inc.
• Diaceutics plc
• Epic Sciences Inc.
• Foundation Medicine Inc.
• Genomic Health Inc.
• Grail Inc.
• Hologic Inc.
• HTG Molecular Diagnostics Inc.
• Inivata Ltd.
• Invivoscribe Inc.
• MolecularMD Corporation
• Natera Inc.
• NeoGenomics Laboratories Inc.
• Personal Genome Diagnostics Inc.
• Precision Therapeutics Inc.
• Prometheus Laboratories Inc.
• Sividon Diagnostics GmbH
• Sysmex Corporation
• Ventana Medical Systems
• Vermillion Inc.
Regional Dominance: Which Area Leads the Global Companion Diagnostics Market?
North America was the largest region in the companion diagnostics market in 2024
